Podcasts by Category

AMC Clinical Deep Dive

AMC Clinical Deep Dive

Medistanding

This platform serves as an independent educational initiative. All content is synthesised from various academic sources and is not a direct reproduction of any official material. It is NOT affiliated with, endorsed by, or sponsored by the AMC or any official body. All trademarks or original content belong to their respective owners. We provide personal learning insights and clinical interpretations to support IMGs in developing their clinical reasoning skills. It may contain errors and does NOT constitute medical advice. For further exploration, please visit the official website.

228 - E3S16 - Managing Candidiasis in Australian Clinical Exams
0:00 / 0:00
1x
  • 228 - E3S16 - Managing Candidiasis in Australian Clinical Exams

    Welcome to Season 3 of AMC Clinical Deep Dive!


    Although Candida species can be normal flora and thrush is not considered a sexually transmitted infection (STI), it causes significant distress and presents frequently in OSCE scenarios. This episode breaks down the ASHM guidelines for acing this station. Learn the critical distinction between uncomplicated thrush and recurrent candidiasis (≥4 episodes/year requiring MCS culture and speciation). We cover first-line oral Fluconazole stat dosing versus topical clotrimazole, pregnancy safety traps where oral azoles and boric acid are strictly contraindicated, avoiding local irritants, and recognising why contact tracing and Test of Cure are unnecessary.


    #AMCClinicalExam #VulvovaginalCandidiasis #Thrush #OSCE #FluconazolePregnancyTrap #ASHMGuidelines #IMGAustralia #RecurrentCandidiasis #Candidaalbicans #Clotrimazole


    Pro Tip: In your OSCEs, the biggest trap candidates fall into is prescribing oral Fluconazole to a pregnant patient! Oral azoles and boric acid are strictly contraindicated in pregnancy—you must use a 7-day course of topical azoles (e.g., Clotrimazole cream) instead. Furthermore, win major safety points by stating that contact tracing and Test of Cure (TOC) are NOT required for candidiasis, but explicitly warning the patient that topical antifungal creams can damage latex condoms!

    🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.

    Mon, 02 Nov 2026 - 19min
  • 227 - E3S15 - Trichomoniasis Management in Australian Clinical Exams

    Welcome to Season 3 of AMC Clinical Deep Dive!


    Caused by the flagellated protozoan Trichomonas vaginalis, this infection typically presents as profuse, frothy, malodorous vaginal discharge or asymptomatic urethritis. This episode breaks down the ASHM guidelines for OSCE success. Learn key diagnostic protocols, including high vaginal swab NAAT, and master first-line therapy: Metronidazole 400mg BD for 7 days (avoiding alcohol). We cover critical exam safeguards: treating current sexual partners presumptively—even if their test returns negative—navigating Category B2 pregnancy safety, and recognising that Test of Cure is not routinely recommended. Deliver a safe, patient-centred plan today!


    #AMCClinicalExam #Trichomoniasis #OSCE #Trichomonasvaginalis #MetronidazoleProtocol #ASHMGuidelines #IMGAustralia #HighVaginalSwabNAAT #PresumptivePartnerTreatment


    Pro Tip: In your OSCE, do not fail the station by withholding treatment from a partner whose test comes back negative! Because Trichomonas vaginalis clears spontaneously much faster in partners with a penis, they frequently test false-negative—so you must explicitly state that you will treat current sexual partners presumptively. Additionally, score top clinical safety marks by remembering that Test of Cure (TOC) is NOT routinely recommended unless the patient remains symptomatic, and warn patients strictly to avoid alcohol during treatment and for 24 hours after Metronidazole to prevent disulfiram-like reactions!


    🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.

    Mon, 26 Oct 2026 - 21min
  • 226 - E3S14 - Syphilis Management for Australian Clinical Exams

    Welcome to Season 3 of AMC Clinical Deep Dive!


    Driven by Treponema pallidum, syphilis prevalence is rising across Australia, particularly among women of reproductive age. This episode deconstructs the ASHM guidelines for OSCE success. Learn to differentiate early (<2 years) versus late (>2 years) syphilis, interpret complex serology (CMIA screening, TPPA confirmation, and RPR activity tracking), and administer first-line Benzathine Benzylpenicillin (2.4 MU IMI stat vs. 3 weekly doses). We cover critical safety steps: warning patients about the Jarisch-Herxheimer reaction, managing syphilis in pregnancy, executing 3/6/12-month contact tracing, and evaluating a 4-fold RPR drop at follow-up.


    #AMCClinicalExam #SyphilisOSCE #Treponemapallidum #BenzathinePenicillin #RPRTiter #JarischHerxheimerReaction #IMGAustralia #ASHMGuidelines #CongenitalSyphilis #ContactTracing


    Pro Tip: In your OSCE, never mistake early latent syphilis for late latent syphilis! If the exact duration of infection is uncertain, always treat as late latent (>2 years) with 3 weekly doses of Benzathine Benzylpenicillin (2.4 MU IMI weekly). Always forewarn patients about the Jarisch-Herxheimer reaction (fever, rigours, and headache 6–12 hours post-treatment) so they aren't alarmed by acute systemic symptoms. For pregnant patients, penicillin is non-negotiable—if allergic, they must undergo hospital desensitisation because alternative regimens are not proven effective in preventing congenital syphilis. Finally, document mandatory Syphilis Registry / Health Department notification and schedule RPR testing at 3 and 6 months, aiming for a 4-fold drop in titer (e.g., from 1:16 to 1:4) to secure top clinical reasoning marks!


    🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.

    Mon, 19 Oct 2026 - 15min
  • 225 - S3E13 - Resistance Guided Mycoplasma Genitalium Treatment

    Welcome to Season 3 of AMC Clinical Deep Dive!


    Driven by alarming macrolide resistance (>60% in Australia), Mycoplasma genitalium (M. gen.) management requires resistance-guided sequential therapy. This episode deconstructs the ASHM guidelines for OSCE success. Learn why routine asymptomatic screening is contraindicated and why Doxycycline (100mg BD for 7 days) must precede targeted treatment—either Azithromycin for susceptible strains or Moxifloxacin for resistant infections. We cover 14-day Moxifloxacin PID protocols, pregnancy safety traps, contact tracing for ongoing partners, and timing the mandatory 14–21 day Test of Cure.


    #AMCClinicalExam #MycoplasmaGenitalium #OSCE #ResistanceGuidedTherapy #MoxifloxacinProtocol #MacrolideResistance #TestofCure #IMGAustralia #ASHMGuidelines #DoxycyclineSequentialTherapy


    Pro Tip: In your OSCE, never prescribe single-dose Azithromycin or immediate Moxifloxacin alone! High-scoring candidates demonstrate safety by explicitly using resistance-guided sequential therapy: initiating Doxycycline 100mg BD for 7 days to reduce bacterial load before stepping up to Azithromycin (if susceptible) or Moxifloxacin 400mg daily (if resistant). Highlight key exam traps: routine asymptomatic screening is NOT recommended, Moxifloxacin is Category B3 and avoided in pregnancy (requiring specialist input/Pristinamycin), and a Test of Cure (TOC) by NAAT must be delayed until 14–21 days post-treatment to avoid false positives!


    🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.

    Mon, 12 Oct 2026 - 21min
  • 224 - S3E12 - LGV Management in Australian Clinical Exams

    Welcome to Season 3 of AMC Clinical Deep Dive!


    Caused by Chlamydia trachomatis serovars L1–L3, Lymphogranuloma Venereum (LGV) presents as proctitis, genital ulcers, or painful inguinal buboes. This episode deconstructs the ASHM guidelines for acing this complex OSCE scenario. Learn key diagnostic steps: ordering rectal Chlamydia NAAT with mandatory LGV genotyping, and empirically treating for gonorrhoea and HSV while awaiting typing results. We cover the non-negotiable 21-day Doxycycline regimen, 21 days of strict sexual abstinence, 3-to-6-month contact tracing, and a mandatory 6-week Test of Cure. Deliver a safe, high-scoring management plan today!


    #AMCClinicalExam #LGV #LymphogranulomaVenereum #ChlamydiaSerovarsL1-L3 #Doxycycline21Days #ProctitisTreatment #IMGAustralia #ASHMGuidelines #TestofCure #ContactTracing


    Pro Tip: In your OSCE, do not prescribe a standard 7-day chlamydia course for suspected LGV! High-scoring candidates win top safety marks by prescribing Doxycycline 100mg BD for a full 21 days, explaining that chlamydial DNA persists in rectal tissue for up to 16 days. Remember two crucial exam facts: first, perform a Test of Cure (TOC) at 6 weeks (3 weeks after finishing treatment); second, primary care clinicians do NOT need to notify health departments for LGV in Australia, but contact tracing is a high priority (tracing back 3 months for symptomatic cases)!


    🎧 ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Episodes in ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Season 1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (150 clinical scenarios) have been indexed by topic, patient group, discipline, setting, and more to support targeted learning. Use the filters to locate discussions relevant to your study or clinical training.

    Mon, 05 Oct 2026 - 23min
Show More Episodes